1. Home
  2. LSCC vs BLCO Comparison

LSCC vs BLCO Comparison

Compare LSCC & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSCC
  • BLCO
  • Stock Information
  • Founded
  • LSCC 1983
  • BLCO 1853
  • Country
  • LSCC United States
  • BLCO Canada
  • Employees
  • LSCC N/A
  • BLCO N/A
  • Industry
  • LSCC Semiconductors
  • BLCO Ophthalmic Goods
  • Sector
  • LSCC Technology
  • BLCO Health Care
  • Exchange
  • LSCC Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • LSCC 7.5B
  • BLCO 7.0B
  • IPO Year
  • LSCC 1989
  • BLCO 2022
  • Fundamental
  • Price
  • LSCC $54.21
  • BLCO $19.58
  • Analyst Decision
  • LSCC Strong Buy
  • BLCO Buy
  • Analyst Count
  • LSCC 12
  • BLCO 11
  • Target Price
  • LSCC $59.25
  • BLCO $21.30
  • AVG Volume (30 Days)
  • LSCC 2.6M
  • BLCO 442.8K
  • Earning Date
  • LSCC 11-04-2024
  • BLCO 10-30-2024
  • Dividend Yield
  • LSCC N/A
  • BLCO N/A
  • EPS Growth
  • LSCC N/A
  • BLCO N/A
  • EPS
  • LSCC 1.02
  • BLCO N/A
  • Revenue
  • LSCC $562,578,000.00
  • BLCO $4,684,000,000.00
  • Revenue This Year
  • LSCC N/A
  • BLCO $17.44
  • Revenue Next Year
  • LSCC $3.51
  • BLCO $6.18
  • P/E Ratio
  • LSCC $52.91
  • BLCO N/A
  • Revenue Growth
  • LSCC N/A
  • BLCO 18.01
  • 52 Week Low
  • LSCC $40.65
  • BLCO $13.16
  • 52 Week High
  • LSCC $85.69
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • LSCC 56.94
  • BLCO 47.50
  • Support Level
  • LSCC $48.03
  • BLCO $19.31
  • Resistance Level
  • LSCC $55.89
  • BLCO $20.23
  • Average True Range (ATR)
  • LSCC 2.19
  • BLCO 0.48
  • MACD
  • LSCC 0.00
  • BLCO -0.10
  • Stochastic Oscillator
  • LSCC 78.71
  • BLCO 19.37

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: